Trials / Completed
CompletedNCT00852969
Niacin and Endothelial Function in Early CKD
Does Raising HDL-C With Niacin Improve Endothelial Function in Early CKD?
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Tufts Medical Center · Academic / Other
- Sex
- All
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to obtain information on whether raising levels of HDL-cholesterol (the "good" cholesterol) can improve how blood vessels work in kidney disease. This may help us understand the causes leading to high rates of heart disease in kidney disease and also ways to reduce this risk.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Niacin | 1000 mg tablets once per day |
| DRUG | Active Placebo | 100 mg Niacin tablets once per day |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2009-02-27
- Last updated
- 2014-05-06
- Results posted
- 2014-05-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00852969. Inclusion in this directory is not an endorsement.